B

BMC Medical Co Ltd
SZSE:301367

Watchlist Manager
BMC Medical Co Ltd
SZSE:301367
Watchlist
Price: 68.07 CNY -3.86% Market Closed
Market Cap: 6.1B CNY
Have any thoughts about
BMC Medical Co Ltd?
Write Note

BMC Medical Co Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BMC Medical Co Ltd
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
B
BMC Medical Co Ltd
SZSE:301367
Total Liabilities & Equity
ÂĄ2.9B
CAGR 3-Years
85%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Total Liabilities & Equity
ÂĄ2.6B
CAGR 3-Years
63%
CAGR 5-Years
51%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Total Liabilities & Equity
ÂĄ15.6B
CAGR 3-Years
9%
CAGR 5-Years
16%
CAGR 10-Years
22%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Total Liabilities & Equity
ÂĄ60.6B
CAGR 3-Years
21%
CAGR 5-Years
21%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Total Liabilities & Equity
ÂĄ5.5B
CAGR 3-Years
7%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Total Liabilities & Equity
ÂĄ25.3B
CAGR 3-Years
38%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

BMC Medical Co Ltd
Glance View

Market Cap
6.1B CNY
Industry
Health Care

BMC Medical Co. Ltd. principally engages in the research, development, production, and sale of medical equipment and consumable products in the field of respiratory health. The company is headquartered in Beijing, Beijing and currently employs 843 full-time employees. The company went IPO on 2022-11-01. The firm's products mainly include non-invasive home ventilators, ventilation masks, sleep monitors and high-flow humidified oxygen therapy devices. The firm also provides respiratory health chronic disease management services. The firm focuses on the treatment of patients with sleep apnea-hypopnea syndrome (SAHS), mainly obstructive sleep apnea syndrome (OSA), as well as patients with respiratory insufficiency, mainly chronic obstructive pulmonary disease (COPD), providing a full-cycle and multi-scenario overall solution for treatment services.

Intrinsic Value
63.17 CNY
Overvaluation 7%
Intrinsic Value
Price
B

See Also

What is BMC Medical Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
2.9B CNY

Based on the financial report for Dec 31, 2023, BMC Medical Co Ltd's Total Liabilities & Equity amounts to 2.9B CNY.

What is BMC Medical Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 3Y
85%

Over the last year, the Total Liabilities & Equity growth was 0%. The average annual Total Liabilities & Equity growth rates for BMC Medical Co Ltd have been 85% over the past three years .

Back to Top